Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

78.07 -1.51 (-1.90%)

Streaming Delayed Price Updated: 3:51 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ANI Pharmaceuticals: Q4 Earnings Insights ↗

March 15, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:50 AM. Here's what investors need to know about the announcement....

Via Benzinga

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

March 15, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

ANI Pharmaceuticals's Earnings Outlook ↗

March 14, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team

February 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders

January 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances ↗

January 05, 2022

Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference

January 03, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail ↗

December 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...

Via Benzinga

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP

December 21, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada ↗

December 20, 2021

Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

7 of the Best Small-Cap Stocks to Buy Before 2022 ↗

December 16, 2021

With 2021 coming to a close and a new year upon us, it's time to get a head start on some of the best small-cap stocks to buy.

Via InvestorPlace

This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position ↗

December 13, 2021

Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses

November 22, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021

November 22, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma

November 11, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock

November 08, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock

November 03, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

November 03, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021 ↗

November 02, 2021

Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript ↗

November 01, 2021

ANIP earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates ↗

November 01, 2021

ANI Pharmaceuticals Inc (NASDAQ: ANIP) has reported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of $49.70 million. The company achieved an...

Via Benzinga

Topics Earnings

64 Biggest Movers From Yesterday ↗

November 02, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...

Via Benzinga

Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide ↗

November 01, 2021

Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81. The U.S. has the...

Via Benzinga

Topics Stocks

Dow, SPX Fall From Record Intraday Highs ↗

November 01, 2021

Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today ↗

November 01, 2021

The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.

Via The Motley Fool

Topics Bankruptcy Lawsuit

Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump ↗

November 01, 2021

Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98. The U.S. has the...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.